Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety and Efficacy Study of Prosaptide to Treat Neuropathic Pain in HIV-Positive Patients

This study has been terminated.
Neurologic AIDS Research Consortium (NARC)
Information provided by:
Savient Pharmaceuticals Identifier:
First received: June 30, 2005
Last updated: February 2, 2006
Last verified: January 2006
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: December 2004
  Estimated Primary Completion Date: No date given
Publications automatically indexed to this study by Identifier (NCT Number):